ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

XGN vs YDES // OPTIONS IMPLIED MOVE & PUT/CALL SKEW

Exagen Inc. (NASDAQ) VS. YD Bio Limited (NASDAQ) • 15-METRIC TALLY: XGN 5 — YDES 4
■ METRIC PARITY
options-implied-move
—
options-implied-move
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (XGN VS. YDES) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC XGN YDES SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 58.30% 28.10% +30.20 XGN /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -20.00% -15.00 YDES /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield -6.77% -1.93% -4.84 YDES /fcf-yield <GO>
Operating Margin -21.10% -60.00% +38.90 XGN /operating-margins <GO>
Net Profit Margin -30.00% -60.00% +30.00 XGN /net-margins <GO>
Revenue Growth (YoY) 19.70% 16.90% +2.80 XGN /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 0.20 13.44 -13.24 YDES /balance-sheet <GO>
Piotroski F-Score Quality 4/9 4/9 0.00 TIE /piotroski-score <GO>
Options Implied Move & Put/Call Skew ACTIVE — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 59.9 51.7 +8.20 XGN /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $210.8M $415.8M -$205.0M YDES /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR XGN REV YDES REV XGN GROSS % YDES GROSS % XGN FCF YDES FCF
FY 2025 $66.6M $596.8K 58.3% 28.1% -$14.3M -$8.0M
FY 2024 $55.6M $510.4K 59.5% 30.4% -$13.8M -$1.3M
FY 2023 $52.5M $350.1K — — -$14.5M -$55.7K
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
XGN // BETA —
YDES // BETA —